| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C13H15N5O2 |
| Molar mass | 273.296 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Fasiplon (RU 33203) is anonbenzodiazepineanxiolytic drug from theimidazopyrimidine family of drugs.
Fasiplon binds strongly to benzodiazepine sites on theGABAAreceptor and has similaranxiolytic effects in animals, but with lesssedative ormuscle relaxant action.[1] It was developed by a team atRoussel Uclaf in the 1990s[2]